Telo Genomics Corp.
Research Telo Genomics Corp. (TELO.V) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerTELO.V
- ExchangeV
- CountryCanada
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyCAD
- Financial periodQ1 2026
- RevenueCAD 0
- Net income-CAD 560.48K
- Free cash flow-CAD 325.61K
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 0 | -CAD 2.62M | -CAD 2.20M | n/a | n/a | CAD 50.11K | CAD 161.31K | -CAD 553.33K |
About Telo Genomics Corp.
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What does Telo Genomics Corp. do?
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments.